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The acquired immunodeficiency syndrome (AIDS)
was first described in homosexual men in the
United States in 1981.1 Later, in 1983 and 1984,
respectively, French and American scientists iso-
lated the human immunodeficiency virus (HIV)
as the causative agent of AIDS.2–4 This year, 2008,
marks the 25th year since the initial isolation and
description of HIV-1. Globally, 33 million people
are infected with HIV at present, and cumulatively
25 million have died from AIDS. The US Centers
for Disease Control (CDC) estimates that 1.1 mil-
lion Americans are currently infected with HIV,
and that 56,300 people become newly infected
annually in the US. Amongst the 1.1 million esti-
mated infected individuals in America, the US
CDC surmises that one in five (approximately
233,000) do not know that they are infected.
How is the AIDS/HIV situation in Taiwan and
China? Arguably, HIV/AIDS is a less visible topic
in Taiwan and China5 compared to the US and
other parts of the world. Today, China has an esti-
mated 700,000 infections, with 38% of the cases
arising from heterosexual transmission.6 Genotyp-
ically, the major HIV-1 strains in China appear to
be circulating recombinant forms (CRF) of dif-
ferent clades. Hence, the HIV-1 CRF_BC strain cur-
rently accounts for over 50% of infections, while
the HIV-1 Thai B (B’) strain contributes to roughly
31% of total prevalence. In Taiwan, 15,011 individ-
uals are HIV-infected, of whom 4250 have pro-
gressed to AIDS and 1870 have died cumulatively
from AIDS (Figure). The major genotype of the
virus in Taiwan is subtype B and CRF_AE, with a
recent emergence of CRF_BC (similar to that in
China) in intravenous drug users.7 The presence
of CRF forms of HIV suggests that the viruses in
China and Taiwan are evolving dynamically. The
current numbers in China and Taiwan suggest a
serious disease that could become much worse
in the future.
Going forward, now 25 years after the discovery
of HIV, how should Taiwan address her AIDS/HIV
question? There are no easy answers. Today, there
are at least 23 US Food and Drug Administration-
approved antiretroviral drugs that can be used to
treat HIV-1 in vivo. Taiwan citizens have access to
several of these therapeutic drugs, which in many
ways have converted HIV-1 infection from an acute
death sentence to a chronic treatable disease. Nev-
ertheless, recent failures in the development of a
prophylactic HIV-1 vaccine8 and protective micro-
bicides9 have cast sobering doubts on “curative”
solutions. Hence, the reality is that HIV/AIDS will
likely be with us for decades to come. In view of
that scenario, it is mandatory that sound educa-
tion, prevention, and public health measures come
from both governmental and non-governmental
sources.10 One area that Taiwan should not ne-
glect is the development of self-sufficiency in lead-
ership for basic and clinical HIV-1 research. The
virus is a clever foe with many faces; the problem
that faces Asia may be sufficiently nuanced that
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it will not fit an American or European solution.
Investing in the fundamental infrastructure and
personnel required for the science and medicine
of HIV/AIDS will put Taiwan in good stead should
this pandemic rage for another 25 years.
Disclaimer
The views expressed here are the personal opin-
ions of the authors and do not reflect the views
of their employers, the US National Institutes of
Health or the National Taiwan University.
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Figure. Reported cases of HIV/AIDS by year of diagnosis in Taiwan, 1984–2007. Cumulative HIV cases: 15,011; cumulative
AIDS cases: 4250; cumulative HIV/AIDS deaths: 1870. (Reproduced with permission from http://www.cdc.gov.tw/
public/Attachment/81810522971.xls.)
